The chikungunya virus, transmitted by Aedes aegypti and Aedes albopictus mosquitoes and responsible for more than 900 deaths in Brazil since it arrived around ten years ago, is capable of spreading through the blood, reaching ...
Mar 12, 2024
0
23
A pioneering Phase I CAR T cell therapy trial for the treatment of glioblastoma at City of Hope demonstrates promising clinical activity against incurable brain tumors, according to research published in Nature Medicine.
Mar 7, 2024
0
16
In a discovery that opens the door to a less invasive way of treating some serious disorders before birth, UC San Francisco scientists have found that delivering medicine through amniotic fluid is as effective as delivering ...
Mar 4, 2024
0
23
There lies a paradox in sleep. Its apparent tranquility juxtaposes with the brain's bustling activity. The night is still, but the brain is far from dormant. During sleep, brain cells produce bursts of electrical pulses that ...
Feb 28, 2024
1
92
Studies at MIT and elsewhere are producing mounting evidence that light flickering and sound clicking at the gamma brain rhythm frequency of 40 Hz can reduce Alzheimer's disease (AD) progression and treat symptoms in human ...
Feb 28, 2024
2
365
While newly approved drugs for Alzheimer's show some promise for slowing the memory-robbing disease, the current treatments fall far short of being effective at regaining memory. What is needed are more treatment options ...
Feb 1, 2024
0
123
In a study published in Nature, South Korean researchers led by Director Koh Gou Young of the Center for Vascular Research within the Institute for Basic Science (IBS) have uncovered a distinctive network of lymphatic vessels ...
Jan 26, 2024
0
92
A team of international researchers, led by UC San Francisco, has completed the first large-scale study of posterior cortical atrophy, a baffling constellation of visuospatial symptoms that present as the first symptoms of ...
Jan 22, 2024
0
43
A large team of neuroscientists and neurodegenerative disease specialists affiliated with multiple entities across the Netherlands, working with colleagues from the U.S., Belgium, the U.K. and Sweden, has found five categories ...
A combination of only 11 proteins can predict long-term disability outcomes in multiple sclerosis (MS) for different individuals. The identified proteins could be used to tailor treatments to the individual based on the expected ...
Jan 9, 2024
0
37
